Keith Regnante

Keith Regnante has served as Chief Financial Officer since February 2020. Prior to joining, Mr. Regnante served as Chief Financial Officer at Wave Life Sciences and was Vice President of Finance at Shire, where he was on the Financial Leadership Team and the R&D Leadership Team. Previously he held multiple finance positions at Biogen dating back to 1999, including Senior Director of Corporate Finance and Senior Director of Worldwide R&D Finance. Prior to these roles, Mr. Regnante worked as a consultant at The Boston Consulting Group. He holds a B.A. in Economics from Tufts University and an M.B.A. from the MIT Sloan School of Management.